{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:20:52Z","timestamp":1786627252117,"version":"build-2736575974"},"reference-count":40,"publisher":"China Science Publishing & Media Ltd.","issue":"7","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2022,7,1]]},"DOI":"10.3724\/abbs.2022069","type":"journal-article","created":{"date-parts":[[2022,5,29]],"date-time":"2022-05-29T13:20:25Z","timestamp":1653830425000},"page":"1008-1020","update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":11,"title":["TMEM106A transcriptionally regulated by promoter methylation is involved in invasion and metastasis of hepatocellular carcinoma"],"prefix":"10.3724","volume":"54","author":[{"given":"Shiming","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinglei","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lina","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxian","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luxi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialiang","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"Siegel RL","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin, 2019, 69: 7-34.","journal-title":"CA Cancer J Clin"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"Hanahan D","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144: 646-674.","journal-title":"Cell"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1038\/nrc3130","volume":"11","author":"Baylin SB","year":"2011","unstructured":"Baylin SB, Jones PA. A decade of exploring the cancer epigenome \u2014 biological and translational implications. Nat Rev Cancer, 2011, 11: 726-734.","journal-title":"Nat Rev Cancer"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.gde.2012.02.008","volume":"22","author":"Sandoval J","year":"2012","unstructured":"Sandoval J, Esteller M. Cancer epigenomics: beyond genomics. Curr Opin Genet Dev, 2012, 22: 50-55.","journal-title":"Curr Opin Genet Dev"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.cell.2011.09.024","volume":"147","author":"Valastyan S","year":"2011","unstructured":"Valastyan S, Weinberg RA. Tumor metastasis: molecular insights and evolving paradigms. Cell, 2011, 147: 275-292.","journal-title":"Cell"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s13046-018-0988-8","volume":"37","author":"Su Y","year":"2018","unstructured":"Su Y, Hopfinger NR, Nguyen TD, Pogash TJ, Santucci-Pereira J, Russo J. Epigenetic reprogramming of epithelial mesenchymal transition in triple negative breast cancer cells with DNA methyltransferase and histone deacetylase inhibitors. J Exp Clin Cancer Res, 2018, 37:","journal-title":"J Exp Clin Cancer Res"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1172\/JCI39675","volume":"119","author":"Kalluri R","year":"2009","unstructured":"Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest, 2009, 119: 1417-1419.","journal-title":"J Clin Invest"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"Pastushenko I","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT transition states during tumor progression and metastasis. Trends Cell Biol, 2019, 29: 212-226.","journal-title":"Trends Cell Biol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.canlet.2014.11.044","volume":"358","author":"Zhou SL","year":"2015","unstructured":"Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J. CXCR2\/CXCL5 axis contributes to epithelial\u2013mesenchymal transition of HCC cells through activating PI3K\/Akt\/GSK-3\u03b2\/Snail signaling. Cancer Lett, 2015, 358: 124-135.","journal-title":"Cancer Lett"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"7294","DOI":"10.1158\/1078-0432.CCR-11-1327","volume":"17","author":"Zhu K","year":"2011","unstructured":"Zhu K, Dai Z, Pan Q, Wang Z, Yang GH, Yu L, Ding ZB. Metadherin promotes hepatocellular carcinoma metastasis through induction of epithelial\u2013mesenchymal transition. Clin Cancer Res, 2011, 17: 7294-7302.","journal-title":"Clin Cancer Res"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"15449","DOI":"10.1073\/pnas.1004900107","volume":"107","author":"Taube JH","year":"2010","unstructured":"Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA, 2010, 107: 15449-15454.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/ncb3513","volume":"19","author":"Krebs AM","year":"2017","unstructured":"Krebs AM, Mitschke J, Lasierra Losada M, Schmalhofer O, Boerries M, Busch H, Boettcher M. The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nat Cell Biol, 2017, 19: 518-529.","journal-title":"Nat Cell Biol"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1182\/blood-2016-05-714493","volume":"129","author":"Li H","year":"2017","unstructured":"Li H, Mar BG, Zhang H, Puram RV, Vazquez F, Weir BA, Hahn WC. The EMT regulator ZEB2 is a novel dependency of human and murine acute myeloid leukemia. Blood, 2017, 129: 497-508.","journal-title":"Blood"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.stem.2014.12.005","volume":"16","author":"Jung HY","year":"2015","unstructured":"Jung HY, Yang J. Unraveling the TWIST between EMT and cancer stemness. Cell Stem Cell, 2015, 16: 1-2.","journal-title":"Cell Stem Cell"},{"key":"CITATION15","doi-asserted-by":"publisher","first-page":"7825","DOI":"10.1002\/jcb.28057","volume":"120","author":"Liu J","year":"2019","unstructured":"Liu J, Zhu H. TMEM106A inhibits cell proliferation, migration, and induces apoptosis of lung cancer cells. J Cell Biochem, 2019, 120: 7825-7833.","journal-title":"J Cell Biochem"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Ally A","year":"2017","unstructured":"Ally A, Balasundaram M, Carlsen R, Chuah E, Clarke A, Dhalla N, Holt RA. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell, 2017, 169: 1327-1341.e23.","journal-title":"Cell"},{"key":"CITATION17","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-004-0564-9","volume":"130","author":"Li Y","year":"2004","unstructured":"Li Y, Tian B, Yang J, Zhao L, Wu X, Ye SL, Liu YK. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics. J Cancer Res Clin Oncol, 2004, 130:","journal-title":"J Cancer Res Clin Oncol"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1002\/hep.25907","volume":"56","author":"Zhou SL","year":"2012","unstructured":"Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma. Hepatology, 2012, 56: 2242-2254.","journal-title":"Hepatology"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"9821","DOI":"10.1073\/pnas.93.18.9821","volume":"93","author":"Herman JG","year":"1996","unstructured":"Herman JG, Graff JR, My\u00f6h\u00e4nen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA, 1996, 93: 9821-9826.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/path.4395","volume":"234","author":"Dai Z","year":"2014","unstructured":"Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu XT, Chen Q. Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. J Pathol, 2014, 234: 316-328.","journal-title":"J Pathol"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"Liberzon A","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database(MSigDB) hallmark gene set collection. Cell Syst, 2015, 1: 417-425.","journal-title":"Cell Syst"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"Subramanian A","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA, 2005, 102: 15545-15550.","journal-title":"Proc Natl Acad Sci USA"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1158\/1078-0432.CCR-11-2450","volume":"18","author":"Heller G","year":"2012","unstructured":"Heller G, Weinzierl M, Noll C, Babinsky V, Ziegler B, Altenberger C, Minichsdorfer C. Genome-wide miRNA expression profiling identifies miR-3 and miR-193a as targets for De methylation in non\u2013small cell lung cancers. Clin Cancer Res, 2012, 18: 1619-1629.","journal-title":"Clin Cancer Res"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1186\/s12864-015-1847-z","volume":"16","author":"Koch A","year":"2015","unstructured":"Koch A, De Meyer T, Jeschke J, Van Criekinge W. MEXPRESS: visualizing expression, DNA methylation and clinical TCGA data. BMC Genomics, 2015, 16:","journal-title":"BMC Genomics"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1002\/ijc.31232","volume":"142","author":"Liu W","year":"2018","unstructured":"Liu W, Wang S, Sun Q, Yang Z, Liu M, Tang H. DCLK1 promotes epithelial\u2010mesenchymal transition via the PI3K\/Akt\/NF\u2010\u03baB pathway in colorectal cancer. Int J Cancer, 2018, 142: 2068-2079.","journal-title":"Int J Cancer"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/ijc.32207","volume":"145","author":"Zhang Y","year":"2019","unstructured":"Zhang Y, Cheng H, Li W, Wu H, Yang Y. Highly\u2010expressed P2X7 receptor promotes growth and metastasis of human HOS\/MNNG osteosarcoma cells via PI3K\/Akt\/GSK3\u03b2\/\u03b2\u2010catenin and mTOR\/HIF1\u03b1\/VEGF signaling. Int J Cancer, 2019, 145: 1068-1082.","journal-title":"Int J Cancer"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/ijc.31248","volume":"142","author":"Yang K","year":"2018","unstructured":"Yang K, Li Y, Lian G, Lin H, Shang C, Zeng L, Chen S. KRAS promotes tumor metastasis and chemoresistance by repressing RKIP via the MAPK-ERK pathway in pancreatic cancer. Int J Cancer, 2018, 142: 2323-2334.","journal-title":"Int J Cancer"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semcancer.2019.08.018","volume":"60","author":"Marx S","year":"2020","unstructured":"Marx S, Dal Maso T, Chen JW, Bury M, Wouters J, Michiels C, Le Calv\u00e9 B. Transmembrane (TMEM) protein family members: poorly characterized even if essential for the metastatic process. Semin Cancer Biol, 2020, 60: 96-106.","journal-title":"Semin Cancer Biol"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"7763","DOI":"10.2147\/OTT.S179725","volume":"11","author":"Liu Z","year":"2018","unstructured":"Liu Z, An H, Song P, Wang D, Li S, Chen K, Pang Q. Potential targets of TMEM176A in the growth of glioblastoma cells. OTT, 2018, 11: 7763-7775.","journal-title":"OTT"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.biopha.2018.05.016","volume":"104","author":"Shen K","year":"2018","unstructured":"Shen K, Yu W, Yu Y, Liu X, Cui X. Knockdown of TMEM45B inhibits cell proliferation and invasion in gastric cancer. Biomed PharmacoTher, 2018, 104: 576-581.","journal-title":"Biomed PharmacoTher"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40291-018-0376-2","volume":"23","author":"Rizza R","year":"2019","unstructured":"Rizza R, Hackmann K, Paris I, Minucci A, De Leo R, Schrock E, Urbani A. Novel BRCA1 large genomic rearrangements in Italian breast\/ovarian cancer patients. Mol Diagn Ther, 2019, 23: 121-126.","journal-title":"Mol Diagn Ther"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1007\/s10565-021-09582-4","volume":"37","author":"Bhat S","year":"2021","unstructured":"Bhat S, Kabekkodu SP, Adiga D, Fernandes R, Shukla V, Bhandari P, Pandey D. ZNF471 modulates EMT and functions as methylation regulated tumor suppressor with diagnostic and prognostic significance in cervical cancer. Cell Biol Toxicol, 2021, 37: 731-749.","journal-title":"Cell Biol Toxicol"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/s41556-020-0560-6","volume":"22","author":"Moro L","year":"2020","unstructured":"Moro L, Simoneschi D, Kurz E, Arbini AA, Jang S, Guaragnella N, Giannattasio S. Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis. Nat Cell Biol, 2020, 22: 1130-1142.","journal-title":"Nat Cell Biol"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1038\/sj.onc.1206338","volume":"22","author":"Schagdarsurengin U","year":"2003","unstructured":"Schagdarsurengin U, Wilkens L, Steinemann D, Flemming P, Kreipe HH, Pfeifer GP, Schlegelberger B. Frequent epigenetic inactivation of the RASSF1A gene in hepatocellular carcinoma. Oncogene, 2003, 22: 1866-1871.","journal-title":"Oncogene"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jhep.2017.05.015","volume":"67","author":"Wei L","year":"2017","unstructured":"Wei L, Chiu DK, Tsang FH, Law CT, Cheng CL, Au SLK, Lee JM. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. J Hepatol, 2017, 67: 758-769.","journal-title":"J Hepatol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1111\/jcmm.12352","volume":"18","author":"Xu D","year":"2014","unstructured":"Xu D, Qu L, Hu J, Li G, Lv P, Ma D, Guo M. Transmembrane protein 106A is silenced by promoter region hypermethylation and suppresses gastric cancer growth by inducing apoptosis. J Cell Mol Med, 2014, 18: 1655-1666.","journal-title":"J Cell Mol Med"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s13148-016-0261-y","volume":"8","author":"Kristensen LS","year":"2016","unstructured":"Kristensen LS, Hansen JW, Kristensen SS, Tholstrup D, Harsl\u00f8f LB, Pedersen OB, De Nully Brown P. Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma. Clin Epigenet, 2016, 8:","journal-title":"Clin Epigenet"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1093\/carcin\/bgaa115","volume":"42","author":"Hamada K","year":"2021","unstructured":"Hamada K, Tian Y, Fujimoto M, Takahashi Y, Kohno T, Tsuta K, Watanabe SI. DNA hypermethylation of the ZNF132 gene participates in the clinicopathological aggressiveness of \u2018pan-negative\u2019-type lung adenocarcinomas. Carcinogenesis, 2021, 42: 169-179.","journal-title":"Carcinogenesis"},{"key":"CITATION39","doi-asserted-by":"publisher","first-page":"12461","DOI":"10.1038\/srep12461","volume":"5","author":"Dai H","year":"2015","unstructured":"Dai H, Xu D, Su J, Jang J, Chen Y. Transmembrane protein 106a activates mouse peritoneal macrophages via the MAPK and NF-\u03baB signaling pathways. Sci Rep, 2015, 5:","journal-title":"Sci Rep"},{"key":"CITATION40","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cei.13528","volume":"203","author":"Zhang X","year":"2021","unstructured":"Zhang X, Feng T, Zhou X, Sullivan PM, Hu F, Lou Y, Yu J. Inactivation of TMEM106A promotes lipopolysaccharide-induced inflammation via the MAPK and NF-\u03baB signaling pathways in macrophages. Clin Exp Immunol, 2021, 203: 125-136.","journal-title":"Clin Exp Immunol"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CF7152D311494C67A89FE1EF4D6C8F82","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022069","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/CF7152D311494C67A89FE1EF4D6C8F82","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T07:12:11Z","timestamp":1661152331000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2022069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":40,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,6,9]]},"published-print":{"date-parts":[[2022,7,1]]}},"URL":"https:\/\/doi.org\/10.3724\/abbs.2022069","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6,9]]}}}